MMP3 and triple-A syndrome: We show that treatment of mice prone to develop AAA, using two experimental models of AAA, with GsMTx4 prevented AAA incidence by refraining the influx of Ca2+ in VSMC, a necessary co-activator of ECM-degrading enzyme MMP3.